Global Prevalence of Perioperative Outcomes of Surgical Patients with COVID-19: A Systematic Review and Meta-Analysis


 Background: Surgery during the COVID-19 pandemic is too challenging globally especially for low and middle-income countries in which the limping health care system is broken with low testing capacity, sub-optimal postoperative care, lack of anesthesia machine filters, and limited personal protective equipment. Body of evidence is lacking on the prevalence of perioperative outcomes of patients with COVID-19. Therefore, this study is aimed to provide the global prevalence of perioperative outcomes of patients with COVID-19.Methods: A comprehensive search was conducted in PubMed/Medline; Science direct and LILACS from December 2019 to August 2020 without language restriction. The Heterogeneity among the included studies was checked with forest plot, χ2 test, I2 test, and the p-values. All observational studies reporting the prevalence of mortality were included.Results: A total of 515 articles were identified from different databases and 50 articles were selected for evaluation after the successive screening. Twenty-three articles with 2947 participants were included. The Meta-Analysis revealed that the global prevalence of perioperative mortality among COVID-19 patients was 20% (95% CI: 15 to 26). The Meta-Analysis also revealed that the rate of postoperative ICU admission was 15% (95% confidence interval (CI):10 to 21).Conclusion: There is one death for every five COVID-19 patients undergoing surgical procedures which entails mitigating strategies to decrease perioperative mortality, provide less risky anesthetic techniques, and alternative management other than surgical procedures.Registration: This systematic review and meta-analysis was registered in Prospero's international prospective register of systematic reviews (CRD42020203362) on August 10, 2020.


Background
The severe acute respiratory syndrome (SARS-CoV-2) Virus that causes Coronavirus disease 2019  was identi ed in Wuhan, Hubei province of China in December 2019 by the Chinese Center for Disease and Prevention from the throat swab of a patient (1). The Coronavirus infection mainly affects the respiratory system and is presented with fever, dry cough, and di culty of breathing, and lately, the patient may deteriorate associated with pneumonia and acute respiratory distress syndrome (2)(3)(4)(5).
World Health Organization (WHO) situational report revealed that there were more than 20 million laboratory-con rmed cases and 700 thousand deaths globally as of August13, 2020 (6). The American region accounted for the highest number of cases and deaths which was 10 million and 400 thousand respectively (6). The European region accounted for the second-highest con rmed cases and death which were more than 3 million con rmed cases and 200 thousand deaths. Though the COVID-19 pandemic has emerged in the Western Paci c region, China, Hwan city, the number of infected cases, and deaths was the lowest as compared to the American and European regions (6). The number of laboratory-con rmed cases and deaths in the African region was the lowest for the last couple of months but the rate of spreading in this region is increasing at an alarming rate and expected to be very high in the next couple of months if it continues as this rate (6)(7)(8).
The last couple of months' reports in Ethiopia were very low but there were many cases in short periods which is approximately 1000 cases and 10 deaths per day. It is estimated that the number even may be very high because the diagnosis is limited only in big cities.
The challenge of COVID-19 is very high globally due to a lack of proven treatment and the complexity of its transmission (9)(10)(11)(12)(13). However, the impact is more catastrophic for low and middle-income countries because of very poor health care system, high illiteracy and low awareness of the disease and its prevention, lack of skilled health personnel, scarce Intensive Care Unit, a limited number of mechanical ventilators, and prevalence of co-morbidities/infection along with malnutrition (8,(13)(14)(15).
Epidemiological studies showed that patients with co-morbidities including (Asthma, COPD, Tuberculosis, Pneumonia, Acute respiratory distress syndrome (ARDS), Diabetes mellitus, hypertension, renal disease, hepatic disease, and cardiac disease), history of smoking, and history of substance use, male gender and age greater than 60 years were more likely to die or develop undesirable outcomes (16)(17)(18)(19).
The outcomes of patients with coronavirus infection undergoing surgery are very variable. Studies revealed that in-hospital mortality of patients with COVID-19 was very high which varied from 1% 52% of the hospitalized patient (20,21).
Surgery during the COVID-19 outbreak is too challenging to the patient, health care workers, and non-COVID-19 patients (27,28,31,(37)(38)(39)(40) particularly for low and middle-income countries where the limping health care systems were broken with low testing capacity, sub-optimal postoperative care, lack of anesthesia machine lters and limited personal protective equipment(41-44).
Investigating the global prevalence and determinants of perioperative outcomes among patients with COVID-19 undergoing a surgical procedure is very important to reduce patient mortality and morbidity through varies strategies including but not limited to the provision of alternative non-surgical intervention for a moderate and severe case, increasing the number of ICU beds, mechanical ventilator, skilled professionals, and integrated monitors and reducing possible risk factors. Therefore, this systematic review and Meta-Analysis aimed to provide global evidence on the prevalence and determinants of perioperative outcomes among patients with COVID-19 undergoing surgical procedures.

Protocol and registration
The systematic review and meta-analysis were conducted based on the Preferred Reporting Items for Systematic and Meta-analysis (PRISMA) protocols (53). This systematic review and meta-analysis were registered in Prospero's international prospective register of systematic reviews (CRD42020203362) on August 10, 2020.

Types of studies
All observational (case series, cross-sectional, cohort, and case-control) studies reporting the prevalence of mortality and its determinants among surgical patients with coronavirus disease (COVID-19) were incorporated.

Types of participants
All participants with con rmed COVID-19 admitted to the hospital for any kind of care were included.

Outcomes of interest
The primary outcomes of interest were the global prevalence of mortality, morbidity, and complications among patients with COVID-19 worldwide. The number of Lengths of hospital stay and the number of days on a mechanical ventilator was secondary outcomes.

Context
This systematic review incorporated studies conducted worldwide to assess the prevalence of mortality and determinants among surgical patients with COVID-19 underwent surgical procedures

Inclusion criteria
The review included all observational studies conducted to assess mortality in patients with COVID19 who underwent surgical producers.

Exclusion criteria
Studies that didn't report the prevalence of mortality among surgical patients with COVID-19, articles that didn't report full information for data extraction, articles with different outcomes of interest, studies with a methodological score less than fty percent, studies with randomized controlled trials, and Systemic review study design were excluded.

Search strategy
The search strategy was conducted to explore all available published and unpublished studies among surgical COVID-19 patients admitted to the hospital from December 2019 to August 2020 without language restrictions. A comprehensive search was employed in this review. An initial search on PubMed/Medline, Science Direct, and Cochrane Library was carried out followed by an analysis of the text words contained in Title/Abstract and indexed terms. ) OR (regional[Title/Abstract])) OR (spinal [Title/Abstract]))))))))))))))))))) The nal search results were shown with the Prisma ow diagram (Fig 1).

Data extraction
The data from each study were extracted with two independent authors with a customized format excel sheet. The disagreements between the two independent authors were resolved by the third author. The extracted data included: Author names, country, date of publication, sample size, events mortality, need of postoperative mechanical ventilator, the number of days on a mechanical ventilator, presence of comorbidities, and complication. Finally, the data were then imported for analysis in R software version 4.0.2 and STATA 16.

Assessment of methodological quality
Articles identi ed for retrieval were assessed by two independent Authors for methodological quality before inclusion in the review using a standardized critical appraisal Tool adapted from the Joanna Briggs Institute(supplemental Table1). The disagreements between the Authors appraising the articles were resolved through discussion. Articles with average scores greater than fty percent were included for data extraction.

Data analysis
Data analysis was carried out in R statistical software version 4.0.2 and STATA 16. The pooled global prevalence of mortality, comorbidity, and complication among surgical patients with COVID-19 was determined with a random effect model as there was substantial heterogeneity. The Heterogeneity among the included studies was checked with forest plot, χ2 test, I 2 test, and the p-values. Substantial heterogeneity among the included studies was investigated with subgroup analysis.
Publication bias was checked with a funnel plot and the objective diagnostic test was conducted with Egger's correlation, Begg's regression tests, and Trim and ll method. Furthermore, moderator analysis was carried out to identify the independent predictors of mortality among corona cases. The results were presented based on the Preferred Reporting Items for Systemic Reviews and Meta-Analysis (PRISMA)(53).

Selection of studies
A total of 515 articles were identi ed from different databases and 50 articles were selected for evaluation after the successive screening. Twenty-three articles with 2947 participants were included and the rest were excluded with reasons (27, 30-33, 51, 54-69) (Fig 1).

Description of included studies
Twenty-three Articles with 2947 participants were included in the review while twenty-two studies were included in the Meta-Analysis for the prevalence of mortality. Studies with the prevalence of mortality and/or prevalence of comorbidity and prevalence of complications among surgical patients with COVID-19 were included and the characteristics of each included studies were described in (Table 1) and the rest were excluded with reasons.
The included studies were published from December 16, 2019, to June 1, 2020, with sample sizes, ranged from 3 to 1128. The mean (SD) ages of the included studies varied from 33.7±2.75 to 85±8.75 years.
Ten studies with 2134 participants reported the prevalence of comorbidity including hypertension, diabetes mellitus, cardiovascular disease, and dementia as the major comorbidity among surgical patients with COVID-19 while ten studies with 1920 participants reporting the prevalence of complications including pulmonary, acute kidney injury, myocardial Infarction, Thromboembolic disease, infection, and deep wound infection as the major complications.
The prevalence of ICU admission was reported in ten of the included studies while the overall length of hospital stay was reported in thirteen of the included studies.  (Fig 2).
The sub-group analysis was conducted by country, surgical category, and urgency of surgery. The subgroup analysis revealed that perioperative mortality was the highest among emergency surgical patients, 29% (95% con dence interval (CI):-4 to 62%) (Fig3). The perioperative mortality among surgical patients with COVID-19 was found to be higher in France followed by the USA, 92% (95% con dence interval (CI): 64 to 100) and 29% (95% con dence interval (CI):-4 to 62) respectively (supplemental Fig 1). Besides, the perioperative mortality was the highest among any surgical category followed by Orthopedics (supplemental Fig 2).

Prevalence of perioperative complication
The pooled prevalence of perioperative complications was estimated by taking the commonest reported complication among others. The Meta-Analysis showed that the pooled prevalence of perioperative complications among surgical patients with COVID-19 was 14% (95% con dence interval (CI):7 to 22, ten studies, and 1920) participants (Fig 4). The subgroup analysis revealed that Thromboembolic complication, infection, and pulmonary complications were the most common perioperative complications among surgical patients with COVID-19 (supplemental Fig 4).

Mean Duration of hospitalization
The pooled mean duration of hospitalization was estimated from included studies mean duration of hospitalization. The Meta-Analysis revealed that the mean duration of Hospitalization was 10.55 (95% con dence interval (CI): 8.08 to 13.03, 13 studies, 2269 participants) (Fig 5).

Prevalence of clinical presentation
Plenty of clinical manifestations were mentioned in included studies including fever, dry cough, dyspnea, sore throat, and diarrhea. The prevalence of clinical presentation among surgical patients with COVID-19 was 26% (95% con dence interval (CI): 14 to 39, 9 studies, and 1461 participants) (Fig 7).

Meta-regression
The Meta-Analysis showed a substantial heterogeneity between the included studies which entails Metaregression to identify the sources of heterogeneity. Regression Analysis was run for perioperative outcomes with mean age, length of hospital stay, and urgency of surgery moderators. However, none of the moderators showed signi cant association (P-Value >0.05).

Sensitivity analysis and publication bias
Sensitivity analysis was conducted to identify the most in uential study on the pooled summary effect and we didn't nd a signi cant in uencing summary effect. The funnel plot didn't show signi cant publication bias. Besides, egger's regression and Begg's correlation rank correlation failed to show a signi cant difference (p=0.339 and p=2.862) respectively (Fig 8).

Discussion
The Meta-Analysis revealed that the global prevalence of perioperative mortality among surgical patients with COVID-19 was 20% (95% CI: 15 to 26). The sub-group analysis showed that perioperative mortality among COVID-19 patients was very high in patients with emergency surgery, and among studies that included different surgical categories. However, the prevalence of perioperative mortality among COVID-19 patients was the highest in patients with orthopedics surgical procedures. This discrepancy could be explained by the inclusion of low powered included studies in the case of any surgical procedures.
The lower prevalence of perioperative mortality among orthopedic patients compared to other surgical procedures could be because these patients underwent the surgical procedure under spinal anesthesia which decreases airway manipulation, aspiration, postoperative delirium, thromboembolic disease and also improves rapid oral intake and early ambulation.
The Meta-Analysis showed that the prevalence of comorbidity among surgical patients was with COVID-19 was 18% (95% CI: 10 to 25) which is in line with the results of included studies (21,23,29,49,90,91,95). The subgroup analysis showed that dementia was the most prevalent comorbidity followed by hypertension and Diabetes Mellitus. However, the nding of this study was contrary to other studies conducted on the prevalence of comorbidities among patients with COVID-19 where hypertension was the most prevalent comorbidity among patients with COVID-19 (21,25,45,91). This discrepancy might be explained by the inclusion of only one study in this Meta-Analysis that reported a high prevalence of dementia compared to other comorbidities.
Many complications were mentioned in the literature in patients with COVID-19 who underwent surgical procedures (21,29,38,39,52,(89)(90)(91)96). The Meta-Analysis revealed that thromboembolic disease, pulmonary complications, infection, and deep wound infection were the commonest perioperative complications. All these complications were more likely associated with low immunity and prolonged immobility while patients were on a mechanical ventilator.

Quality of evidence
The methodological quality of included studies was moderate to high quality as depicted with Joanna Briggs Institute assessment tool for meta-analysis of observational studies. However, substantial heterogeneity associated with dissimilarities of included studies in sample size, design, and location could affect the allover quality of evidence.

Limitation of the study
The Meta-Analysis included studies with moderate to high methodological quality. However, some of the included studies were low powered and the majority of studies included in this review didn't report data on comorbidity and risk factors to investigate the independent predictors. Besides, there were a limited number of studies in some countries and it would be di cult to provide conclusive evidence with results pooled from fewer studies.

Implication for practice
Body of evidence revealed that perioperative mortality; morbidity and complications were very high among patients with COVID-19. This is a huge challenge especially in resource-limited settings where there are a limited number of ICU beds, mechanical ventilator, integrated patient monitor, skilled professionals combined with malnutrition, and communicable disease. Therefore, a mitigating strategy is required by different stakeholders to combat the catastrophic impacts of the COVID-19 pandemic through creating awareness about preventive measures, implementing protocols for supportive management, management of comorbidities, and prevention of complications.

The implication for further research
The Meta-Analysis revealed that perioperative mortality, complication, rate of ICU admission among surgical COVD-19 patients was very high. However, the included studies were too heterogeneous, low powered, and cross-sectional studies also don't show a temporal relationship between mortality and its determinants. Therefore, further observational and randomized controlled trials are required.

Conclusion
The Meta-Analysis revealed that the prevalence of mortality, perioperative complication, and rate of     Forest plot for the prevalence of perioperative morbidity among surgical patients with COVID-19: The midpoint of each line illustrates the prevalence; the horizontal line indicates the con dence interval, and the diamond shows the pooled prevalence.

Figure 5
Forest plot for the prevalence of perioperative complication among surgical patients with COVID-19: The midpoint of each line illustrates the prevalence; the horizontal line indicates the con dence interval, and the diamond shows the pooled prevalence.  Forest plot for rates postoperative ICU admission among surgical patients with COVID-19: The midpoint of each line illustrates the prevalence; the horizontal line indicates the con dence interval, and the diamond shows the pooled prevalence